{
    "nctId": "NCT03556397",
    "briefTitle": "Sentinel Lymph Node Biopsy in Patients With Breast Cancer After Neoadjuvant Therapy",
    "officialTitle": "Sentinel Lymph Node Biopsy in Patients With Breast Cancer After Neoadjuvant Therapy",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 61,
    "primaryOutcomeMeasure": "Clear indications for SLNB or axillary dissection",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* diagnosis of breast carcinoma confirmed by biopsy\n* neoadjuvant therapy\n* examination of axillary lymph nodes clinically and by ultrasound\n* surgical therapy after neoadjuvant therapy\n\nExclusion Criteria:\n\n* inflammatory breast carcinoma\n* incomplete neoadjuvant therapy\n* previous sentinel lymph node biopsy performed on the same side of the body\n* disagreement with participation in the study\n* other malignities influencing the treatment of breast carcinoma\n* distant metastases",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}